AICDA and Sjogren syndrome: Further, AID, an enzyme expressed in activated B cells and essential for promoting somatic hypermutation and class switch recombination, and increased in patients with Sjögren’s syndrome [49], was reduced in both animal models after treatment, suggesting a diminished functional B cell response.